Wafik S. El-Deiry on Targeting Cell Death in Cancer Therapy

Wafik S. El-Deiry shared a post on LinkedIn:

“Looking forward to visiting MD Anderson Cancer Center Experimental Radiation Oncology, ERO-RO Research Seminar Series and meetings with students.”

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.